Status:
COMPLETED
Effect of Vitamin D Supplementation on Inflammation and Cardiometabolic Risk Factors in Obese Adolescents
Lead Sponsor:
Stanford University
Conditions:
Obesity
Eligibility:
All Genders
11-17 years
Phase:
NA
Brief Summary
Large studies of children show that over half of the children in the United States of America do not have enough vitamin D stored in their bodies. In children who are overweight or obese, the percenta...
Detailed Description
Supplementation with vitamin D at 150,000 IU every 3 months failed to increase serum 25-hydroxy vitamin D (25OHD) or alter inflammatory markers and lipids in overweight and obese youth. Further studie...
Eligibility Criteria
Inclusion
- Ages 11 years to 17.99 years old
- BMI: 85 percentile for age and gender
Exclusion
- Patients who currently receive:
- vitamin D supplementation \>= 400 IU/day
- daily glucocorticoids or anti-epileptics
- Patients who currently have or history of:
- 25-OH vitamin D level \< 10 ng/ml or \> 60 ng/ml
- rickets
- diabetes mellitus
- liver or kidney disease
- malabsorptive disorders
- genetic syndromes associated with obesity (i.e. Prader-Willi)
- lactose deficiency or insufficiency
- galactosemia
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01217840
Start Date
September 1 2010
End Date
August 1 2012
Last Update
November 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305